Meru-Vasimmune, Inc

CalChem Synthesis is a Contract Research Organization (CRO) based in San Diego, CA, specializing in providing high-quality chemistry services to biotech and pharmaceutical companies as well as research institutions. With a leadership team boasting over 35 years of combined experience in drug discovery and development, CalChem Synthesis aims to set the highest standards in delivering custom synthesis, medicinal chemistry, process research and development, scale-up, sourcing and procurement, and consulting services to promote better health for patients. Founded by Dr. Jalal Haddad, a co-founder of Pacific World Discovery and a process research and development scientist at Albany Molecular Research, Inc. (AMRI), CalChem Synthesis is committed to meeting the needs of its customers by offering non-GMP chemistry services and maintaining customer satisfaction. With a team of Ph.D. level organic chemists with extensive experience in the pharmaceutical and chemical industries, CalChem Synthesis is dedicated to making a difference in the field of chemistry.Generated from the website

Zenobia Therapeutics Inc is a San Diego-based company specializing in fragment-based lead discovery for the development of treatments for neurodegenerative diseases. With a focus on the central nervous system (CNS), their products and services have successfully yielded hits for a diverse range of targets worldwide. Founded in 2008, Zenobia Therapeutics expanded in 2014 to include Zenobia Fragments, a division dedicated to supplying highly core diverse fragments and unique reagents for protein solubilization and crystallization. Complementing their product offerings, Zenobia also provides screening and structural biology services to support fragment library purchases, solidifying their position as a leader in fragment-based lead discovery and CNS disease research.Generated from the website